International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Identification of a novel PLS1 heterozygous variant causing autosomal dominant non‑syndromic hearing loss
Congenital disabling hearing impairment is a prevalent sensory deficit, affecting >30,000 newborns annually in China. Non‑syndromic hearing loss (NSHL) accounts for a notable proportion of these cases, ~60% of which are attributed to genetic defects by heterogeneity. Although >120 genes have been linked to NSHL, a definitive molecular diagnosis remains elusive for approximately one‑half of the individuals undergoing genetic testing. In the present study, a Chinese family with NSHL was investigated using next‑generation sequencing of the affected members, with validation by Sanger sequencing. A novel variant was identified, namely plastin‑1 (PLS1) c.981+5G>A. Functional analysis by reverse transcription PCR revealed that this variant induces exon skipping, establishing its pathogenic mechanism. PLS1 encodes the actin‑bundling protein plastin‑1, which is highly abundant in the stereocilia of hair cells. Recent studies have implicated PLS1 in hearing loss; therefore, the present study provides direct functional validation of its pathogenicity, expanding the pathogenic variation spectrum of PLS1 and offering valuable insights into clinical diagnostic advancements and prenatal screening.